Skip to main content

SB 2751 — Hawaii

RELATING TO WORKERS' COMPENSATION.

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Defines compounded prescription drugs for the purposes of the State's Workers' Compensation Law. Limits dispensing of prescription drugs by physician to 30 days after the industrial injury and requires all prescription drugs to be obtained through the employer's pharmacy benefit manager thereafter. Requires prescription drugs not approved by the Food and Drug Administration (FDA), such as compounds, to be identified as compounds when listed on the treatment plan and when billed, and be supported by a statement of medical necessity documenting the case of medical need for a compound drug over an FDA-approved over-the-counter or prescription drug of similar therapeutic effect. Effective 1/1/2077. (SD1)

Official abstract, as published by the legislature.

  • SB 2751 is a bill in the Hawaii Senate, 2026 session, introduced January 23, 2026.
  • Sponsored by IHARA.
  • Current status: introduced.
  • Most recent action (March 3, 2026): The committee on JDC deferred the measure.
  • 2 recorded votes; the most recent, on February 4, 2026, passed 5-0.
  • Subjects: Benefits, Compounded Prescription Drugs, Identification, Non-FDA-Approved Drugs, Physician Dispensing Timeframe, Prescription Drugs.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: IHARA

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Introduced. Milestone
  2. Senate Passed First Reading.
  3. Senate The committee(s) on LBT/HHS has scheduled a public hearing on 02-04-26 1:00PM; Conference Room 225 & Videoconference.
  4. Senate Referred to LBT/HHS, JDC.
  5. Senate The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
  6. Senate The committee(s) on LBT recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in LBT were as follows: 4 Aye(s): Senator(s) Elefante, Lamosao, Moriwaki, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Ihara.

    The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS.: 5 yes 0 no Passed, 100% yes

    The committee(s) on LBT recommend(s) that the measure be PASSED, WITH AMENDMENTS.: 4 yes 0 no, 1 other Passed, 100% yes

  7. Senate Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.
  8. Senate Reported from LBT/HHS (Stand. Com. Rep. No. 2217) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.
  9. Senate The committee(s) on JDC will hold a public decision making on 03-03-26 10:15AM; Conference Room 016 & Videoconference.
  10. Senate The committee on JDC deferred the measure. Latest

Source: Open States. Last checked November 11, 2026. How we keep this accurate ›